 | • レポートコード：MRC2108A478 • 出版社/出版日：Mordor Intelligence / 2021年7月31日 • レポート形態：英文、PDF、167ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：食品・飲料 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、2020年におよそ6,416.8億ドルであったホワイトバイオテクノロジーの世界市場規模が、2021年から2026年の間に年平均15.14％成長すると予測しています。本調査資料では、世界のホワイトバイオテクノロジー市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（アメリカンウィスキー、アイリッシュウィスキー、スコッチウィスキー、カナディアンウィスキー、その他）分析、流通チャンネル別（オントレード、オフトレード）分析、地域別分析（北米、ヨーロッパ、アジア太平洋、その他）、競争状況、市場機会/将来の見通し、新型コロナウイルス感染症の影響などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・ホワイトバイオテクノロジーの世界市場規模：種類別（バイオ燃料、生体材料、生化学、産業用酵素） ・ホワイトバイオテクノロジーの世界市場規模：用途別（化学薬品、製薬、食品・飲料、飼料、その他） ・ホワイトバイオテクノロジーの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、その他） ・競争状況（EUCODIS Bioscience GmbH、DuPont 、Koninklijke DSM NV、BASF SE、Evonik Industries AG、Lonza Group Ltd、Laurus Labs、Corbion NV、Novozymes、Archer Daniels Midland Company） ・市場機会/将来の見通し ・新型コロナウイルス感染症の影響 |
The global white biotech market was valued at USD 641.68 billion in 2020 and is projected to witness a CAGR of 15.14% during the forecast period (2021 – 2026).
COVID-19 has provided a huge stimulus to the white biotech market. Massive efforts to develop vaccines, deploy test kits, develop highly predictive antibody tests, repurpose existing anti-viral drugs, and develop new drugs are causing billions of dollars to flow toward many biotech companies.
In 2021, the biotech sector may have a valuation at or above than the valuation it had in late 2019. Pre-clinical work is expected to be robust. Clinical trials may be near the volume of a year earlier. The regulatory review of clinical trials may be more efficient.
Furthermore, major pharmaceutical market giants are actively involved in product innovation and mergers and acquisitions with small-large pharmaceutical companies in order to make a stronghold on the white biotech market in the future.
Thus, the global COVID-19 pandemic has made a significant impact on the white biotechnology market in terms of innovation in the pharmaceutical industry, which is indicating a fruitful market growth of the category.
Rising consumer demand for green chemicals, majorly in developed regions like North America and Europe who are willing to pay a higher price or a green premium for numerous renewable products, is expected to push manufacturers to employ white biotechnology processes as opposed to traditional chemical manufacturing.
In addition, the rising need from various consumer industries, including automotive and consumer goods, to meet sustainability targets is expected to fuel technology demand over the forecast period.
Industrial biotechnology or white biotechnology is one of the most promising approaches to pollution prevention, resource conservation, and cost reduction. It is often referred to as the third wave in biotechnology. For example, the use of white biotechnology can lead to the reduction of carbon dioxide emissions by as much as 50%, energy consumption by 20%, and water consumption by 75%.
Key Market Trends
Wide Application in Market with Diverse Functionality
The growing awareness about the numerous benefits associated with the application of white biotechnology, such as eco-friendly, reduced manufacturing costs, low wastage generation, and maximum raw material consumption, among others, has boosted the demand for white biotechnology among end-users in the past couple of years. For instance, in pulp and paper production and bleaching, white biotechnology has led to the reduction of chlorine chemicals application by 10-15%. In addition, the process is more efficient, consuming 40% less energy than the traditional manufacturing process. Thus, it makes an important contribution to sustainability and optimum utilization of raw material, thereby reducing negative impacts on the environment while gaining maximum profit from the final product.
In addition, the rising need from various high-end industries, including automotive and consumer goods, to meet sustainability targets is boosting the demand for biofuels across the world.
Asia-Pacific is the Fastest-Growing Region in White Biotech Market
China’s biotech industry has grown rapidly over the past decade, and it is dominated by medical technologies and biologics. The growth is escalated by the biotechnologically altered food ingredients in the market. Thus, players are strategically investing in the local companies.
For instance, in 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweetener, vitamins, personal care, or crop protection products.
In addition to the above-mentioned industrial applications, white biotech has paved great opportunity in Japan’s functional food and beverage segment too due to the increased consumer inclinational toward food and beverage with high nutritional claims. Thus, biochemicals and industrial enzymes are paving great opportunity in the country’s food and beverage domain.
In 2020, DuPont Nutrition & Biosciences (DuPont) launched Powerfresh Special and Powersoft Cake 8010 in Japan, its latest enzyme range for sweet baked goods.
Competitive Landscape
The global white biotech market is highly competitive, with a strong presence of regional and global players in the market, where demand is mostly driven by more adaptation toward consumer awareness on sustainability, efficient productivity, and others. Hence, the players operating in the market are trying to position themselves according to the demographic group.
Further, prominent players like Corbion, ADM, and DuPont in the market have been focusing on developing new and innovative products by targeting the new formulation for the market, thereby engineering the various unexplored microorganisms in the market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Volume – million ton and Value – USD billion)
5.1 By Type
5.1.1 Biofuels
5.1.2 Biomaterials
5.1.3 Biochemicals
5.1.4 Industrial Enzymes
5.2 By Application
5.2.1 Chemicals
5.2.2 Pharmaceuticals
5.2.3 Food and Beverages
5.2.4 Feed
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Spain
5.3.2.5 Italy
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 Rest of the World
5.3.4.1 South America
5.3.4.2 Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 EUCODIS Bioscience GmbH
6.4.2 DuPont
6.4.3 Koninklijke DSM NV
6.4.4 BASF SE
6.4.5 Evonik Industries AG
6.4.6 Lonza Group Ltd
6.4.7 Laurus Labs
6.4.8 Corbion NV
6.4.9 Novozymes
6.4.10 Archer Daniels Midland Company
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
8 IMPACT OF COVID-19 ON THE MARKET